"Fast approval" should mean a quick, thorough medical evaluation — not a skipped one. The fastest legitimate path is typically same-day to 24-hour provider review after a complete health questionnaire.
Luma Health's compounded tirzepatide ($297/month) uses a same online evaluation model: complete a health questionnaire, a licensed provider reviews it, and if appropriate, your prescription moves to a compounding pharmacy the same day.
Patients searching for the "fastest" tirzepatide approval are usually trying to solve for one thing: how quickly can I go from deciding to start treatment to actually having medication in hand. That's a reasonable thing to want — but it's worth being clear about what "fast" should and shouldn't mean.
What "Fast Approval" Should Actually Mean
A legitimate fast-approval process means your online health questionnaire is reviewed quickly by an actual licensed provider — typically within a few hours to 24 hours — not that the evaluation itself is skipped or made superficial in any way. Speed and thoroughness aren't mutually exclusive: a provider can review your BMI, medical history, current medications, and any contraindications in a focused review without it taking days, as long as the questionnaire itself captures the right information upfront.
What should concern you is a platform that approves essentially everyone regardless of what they enter, or that skips the medical evaluation step entirely in the name of speed. That's not fast service — it's a missing safeguard, and it's precisely the kind of shortcut the FDA has warned about with unverified online sellers. The distinction that matters is between a provider that reviews quickly because they're efficient and well-staffed, versus a provider that reviews quickly because there's nothing actually being reviewed — the outcome may look identical from the patient's side (a fast "yes"), but the underlying safety of the process is entirely different.
What Actually Slows Down Approval
When a legitimate provider's review takes longer than expected, it's usually one of a few specific, addressable issues rather than a sign of a broken process. Incomplete answers on the health questionnaire — skipping a field, giving vague responses to medication history questions — is the single most common cause, since a provider needs to follow up for missing information before making a decision. Submitting outside business hours can also add a delay if a platform doesn't staff evening or weekend review, though many telehealth platforms now offer extended coverage specifically to avoid this bottleneck. High-volume periods, such as immediately following a major public event that drives a surge in GLP-1 interest, can also temporarily slow review times across the industry, independent of any single platform's typical performance or staffing levels.
If you've submitted a complete questionnaire during business hours and haven't heard back within the timeframe a provider advertises, following up directly is reasonable and often resolves the delay quickly — sometimes a submission gets stuck in a queue or a notification simply doesn't reach you promptly.
What Happens Immediately After Approval
Once a provider approves your treatment, your prescription is typically transmitted electronically to the compounding pharmacy the same day, which then prepares your medication according to the specific dose your provider prescribed. Compounding isn't instantaneous — pharmacies typically need one to three business days to prepare a compounded prescription correctly, followed by standard shipping time (commonly two to four business days depending on your location and the pharmacy's shipping method). Understanding this pipeline helps set realistic expectations: even a same-day provider approval doesn't mean same-day delivery, since the compounding and shipping steps still take their own reasonable amount of time to complete properly and safely.
A Realistic Timeline
- Health questionnaire: Typically 5-10 minutes to complete online, covering medical history, current medications, and weight-loss goals
- Provider review: Commonly same-day to within 24 hours, depending on the platform and time of submission
- Prescription to pharmacy: If approved, your prescription is sent to a licensed 503A compounding pharmacy the same day or next business day
- Shipping: Typically a few business days to your door once the pharmacy prepares your prescription
End to end, most legitimate platforms get patients from questionnaire to shipped medication within roughly a week, with the provider review itself being the fastest step in that chain when submitted during business hours. It's worth mentally separating these four steps when you're evaluating "how fast" a specific provider actually is, since marketing often emphasizes only the provider-review step (which is genuinely fast at most legitimate platforms) while glossing over the compounding and shipping time that follows, which is largely outside any single provider's ability to compress significantly.
The biggest lever you control is completing your health questionnaire thoroughly and accurately the first time. Incomplete answers or missing medical history are the most common reason a provider needs to follow up before approving, which adds delay that has nothing to do with the platform's actual speed.
Documents and Information to Have Ready
You can meaningfully shorten your own timeline by having key information ready before you start the intake process. This includes your current height and weight (for BMI calculation), a list of current medications and dosages, any relevant diagnosed conditions (type 2 diabetes, hypertension, sleep apnea, thyroid conditions), and your personal and family medical history, particularly regarding thyroid cancer or multiple endocrine neoplasia type 2 (MEN2), which are contraindications for GLP-1 medications. If you've had recent lab work done elsewhere, having those results on hand (even if not required for submission) can sometimes support a faster, more confident review, since the provider isn't relying solely on your self-reported history to make a prescribing decision that affects your safety.
Photo identification and, if applicable, your insurance card should also be ready if you're planning to pursue insurance coverage alongside or instead of a cash-pay option, since incomplete insurance information is a separate common cause of processing delay distinct from the medical evaluation itself and easy to avoid with a bit of preparation.
How Review Requirements Vary by State
Telehealth prescribing regulations differ somewhat by state, and this can affect your specific timeline. Some states require an initial video visit rather than allowing a purely asynchronous, questionnaire-based evaluation, which can add a scheduling step compared to states where an asynchronous review is sufficient. A handful of states have additional documentation requirements for certain controlled substances or specific medication classes, though GLP-1 medications generally aren't subject to unusually restrictive state-specific rules beyond standard telehealth licensure requirements, which keeps the process relatively consistent for most patients regardless of where they live. If your state requires a video visit, ask directly about typical scheduling availability, since this is the step most likely to extend your timeline beyond what a purely asynchronous process would take, particularly if you're trying to complete your evaluation outside standard business hours.
What to Watch For
Be cautious of any platform advertising instant or guaranteed approval regardless of your health profile — that's a sign the evaluation isn't a real clinical review. Legitimate providers can move quickly, but approval should still depend on your actual eligibility (generally BMI ≥30, or ≥27 with a weight-related condition) and the absence of contraindications like a personal or family history of medullary thyroid carcinoma.
How to Actually Compare Providers on Speed
Marketing claims about approval speed are easy to make and hard to verify from the outside, so it's worth looking past the advertised number itself. Check whether a provider publishes its typical review window as a specific range (like "within 24 hours") rather than a vague "fast" claim, since specificity suggests the provider actually tracks and stands behind that metric. Read recent reviews specifically mentioning approval or shipping timelines, since these tend to be more reliable than the provider's own marketing copy, particularly when multiple independent reviewers describe a consistent experience. If possible, ask a direct question to customer support before starting your intake — how a provider answers a timeline question before you've committed any money can be a reasonable proxy for how responsive they'll be once you're an actual patient depending on them for ongoing care.
What to Prioritize
Speed matters, but it shouldn't come at the expense of the fundamentals that keep treatment safe and effective. The providers worth prioritizing are the ones that can move quickly through a genuine evaluation, not the ones that have simply removed the evaluation itself to shave a few hours off the process. In practice, this means favoring a provider that's transparent about its typical review timeline, staffs enough licensed clinicians to actually meet that timeline consistently, and is willing to answer specific questions about its process before you commit any payment information.
- Completing your health questionnaire fully and accurately
- Submitting during business hours when possible for faster provider review
- Having your medical history and current medications ready to enter
- Promise guaranteed approval regardless of health profile
- Skip a real medical evaluation before prescribing
- Aren't transparent about which pharmacy prepares your medication
A real evaluation,
reviewed quickly
Complete your health questionnaire, get reviewed by a licensed provider typically within 24 hours, and start compounded tirzepatide at $297/month if appropriate.
Get Started → Or start your free health assessmentFrequently Asked Questions
With a complete health questionnaire, provider review commonly happens within a few hours to 24 hours at legitimate telehealth platforms. Total time from questionnaire to shipped medication is typically about a week.
Not inherently — a quick, thorough review is a sign of an efficient process. What's a red flag is guaranteed or instant approval regardless of your health profile, which suggests the evaluation isn't a genuine clinical review.
Complete your health questionnaire fully and accurately the first time, with your medical history and current medications ready. Incomplete answers are the most common reason a provider needs to follow up, which adds delay.
Generally, BMI of 30 or higher, or BMI of 27 or higher with a weight-related condition such as type 2 diabetes, hypertension, or sleep apnea. Contraindications include a personal or family history of medullary thyroid carcinoma or MEN2 syndrome.
Typically a few business days once your prescription reaches the compounding pharmacy, though exact timing can vary by location and current pharmacy volume.
The evaluation process is designed to be efficient; confirm the current format (questionnaire-based or video) directly during signup, as this can vary by state licensing requirements.
Incomplete or vague answers on the health questionnaire, which require a provider to follow up before making a decision. Submitting a thorough, complete questionnaire the first time is the biggest factor within your control.
No. After approval, the compounding pharmacy typically needs one to three business days to prepare your prescription, followed by standard shipping time, meaning even a same-day approval doesn't translate to same-day delivery.
Follow up directly with the provider. A submission can occasionally get stuck in a queue, and a quick follow-up message often resolves the delay faster than waiting passively.
References
- U.S. Food and Drug Administration. Prescribing Information for Zepbound (tirzepatide). FDA.gov. 2025. FDA.gov
- U.S. Food and Drug Administration. BeSafeRx: Your Source for Online Pharmacy Information. FDA.gov. 2026. FDA.gov
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PubMed 35658024
- U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. FDA.gov. FDA.gov